en

PRODUCT DETAIL

Zegomib 3,5 mg

Code 3948C
MA number 44/0235/15-S
Product Form: plv ino 3x3,5 mg (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX32 Bortezomib
Shelf life: 36
Container: glass vial
Route of admin.: Subcutaneous and intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 22.06.2015
PIL: PIL_Zegomib 3.5mg_02/2021.pdf  
SPC: SPC_Zegomib 3,5 mg_02/2021.pdf  
Safety feature Yes
Data update: 05.02.2020
eu-flag.png sk-flag.png